Studying the impact of comorbidity on post radical cystectomy survival: have we come a full circle?
- PMID: 31392156
- PMCID: PMC6642976
- DOI: 10.21037/tau.2019.06.06
Studying the impact of comorbidity on post radical cystectomy survival: have we come a full circle?
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures
Comment in
-
Highlighting the road towards new disease-specific comorbidity indices.Transl Androl Urol. 2020 Jun;9(3):1475-1478. doi: 10.21037/tau-20-832. Transl Androl Urol. 2020. PMID: 32676433 Free PMC article. No abstract available.
Comment on
-
Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy.Ann Surg Oncol. 2019 Jun;26(6):1942-1949. doi: 10.1245/s10434-019-07313-y. Epub 2019 Mar 27. Ann Surg Oncol. 2019. PMID: 30919224
References
-
- Boegemann M, Aydin AM, Bagrodia A, et al. Prospects and progress of immunotherapy for bladder cancer. Expert Opin Biol Ther 2017;17:1417-31. - PubMed
-
- Meng X, Press B, Renson A, et al. Discriminative Ability of Commonly Used Indexes to Predict Adverse Outcomes After Radical Cystectomy: Comparison of Demographic Data, American Society of Anesthesiologists, Modified Charlson Comorbidity Index, and Modified Frailty Index. Clin Genitourin Cancer 2018;16:e843-50. 10.1016/j.clgc.2018.02.009 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources